Effects of long-term use of HAART on oral health status of HIV-infected subjects

J Oral Pathol Med (2010) 39: 397–406 Background:  The aim of this study was to determine the effects of long‐term use of highly active antiretroviral therapy (HAART) on oral health status of HIV‐infected subjects. Methods:  Oral examination and measurement of saliva flow rate of both unstimulated an...

Full description

Saved in:
Bibliographic Details
Published inJournal of oral pathology & medicine Vol. 39; no. 5; pp. 397 - 406
Main Authors Nittayananta, Wipawee, Talungchit, Sineepat, Jaruratanasirikul, Sutep, Silpapojakul, Kachornsakdi, Chayakul, Panthip, Nilmanat, Ampaipith, Pruphetkaew, Nannapat
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.05.2010
Subjects
Adult
Age
Antiretroviral Therapy, Highly Active - adverse effects
Burning
Case-Control Studies
CD4 antigen
Cross-Sectional Studies
Data processing
Dental caries
Dental Caries - complications
Female
HAART
Health Status
highly active antiretroviral therapy
HIV
HIV Infections - complications
HIV Infections - drug therapy
Human immunodeficiency virus
Humans
Infection
Linear Models
Logistic Models
Male
Middle Aged
Mouth Diseases - complications
Oral Health
oral lesion
Pain
Periodontal Index
Pigmentation Disorders - etiology
Regression analysis
risk factor
Saliva
salivary flow rate
Salivation - drug effects
Secretory Rate
Side effects
Thailand
Time Factors
Young Adult
Thailand
Online AccessGet full text
ISSN0904-2512
1600-0714
1600-0714
DOI10.1111/j.1600-0714.2009.00875.x

Cover

Abstract J Oral Pathol Med (2010) 39: 397–406 Background:  The aim of this study was to determine the effects of long‐term use of highly active antiretroviral therapy (HAART) on oral health status of HIV‐infected subjects. Methods:  Oral examination and measurement of saliva flow rate of both unstimulated and wax‐stimulated whole saliva were performed in HIV‐infected subjects with and without HAART, and in non‐HIV individuals. The following data were recorded; duration and risk of HIV infection, type and duration of HAART, CD4 cell count, viral load, presence of orofacial pain, oral dryness, oral burning sensation, oral lesions, cervical caries, and periodontal pocket. Multiple logistic regression analysis was performed to determine the effects of long‐term use of HAART on oral health status of HIV‐infected subjects. Results:  One hundred and fifty‐seven HIV‐infected subjects – 99 on HAART (age range 23–57 years, mean 39 years) and 58 not on HAART (age range 20–59 years, mean 34 years) – and 50 non‐HIV controls (age range 19–59 years, mean 36 years) were enrolled. The most common HAART regimen was 2 NRTI + 2 NNRTI. HIV‐infected subjects without HAART showed greater risks of having orofacial pain, oral dryness, oral lesions, and periodontal pockets than those with short‐term HAART (P < 0.01). The subjects with long‐term HAART were found to have a greater risk of having oral lesions than those with short‐term HAART (P < 0.05). The unstimulated and stimulated salivary flow rates of the subjects with HAART were significantly lower than in those without HAART (P < 0.05). Conclusion:  We conclude that long‐term HAART has adverse effects on oral health status of HIV‐infected subjects.
AbstractList J Oral Pathol Med (2010) 39 : 397–406 Background:  The aim of this study was to determine the effects of long‐term use of highly active antiretroviral therapy (HAART) on oral health status of HIV‐infected subjects. Methods:  Oral examination and measurement of saliva flow rate of both unstimulated and wax‐stimulated whole saliva were performed in HIV‐infected subjects with and without HAART, and in non‐HIV individuals. The following data were recorded; duration and risk of HIV infection, type and duration of HAART, CD4 cell count, viral load, presence of orofacial pain, oral dryness, oral burning sensation, oral lesions, cervical caries, and periodontal pocket. Multiple logistic regression analysis was performed to determine the effects of long‐term use of HAART on oral health status of HIV‐infected subjects. Results:  One hundred and fifty‐seven HIV‐infected subjects – 99 on HAART (age range 23–57 years, mean 39 years) and 58 not on HAART (age range 20–59 years, mean 34 years) – and 50 non‐HIV controls (age range 19–59 years, mean 36 years) were enrolled. The most common HAART regimen was 2 NRTI + 2 NNRTI. HIV‐infected subjects without HAART showed greater risks of having orofacial pain, oral dryness, oral lesions, and periodontal pockets than those with short‐term HAART ( P  < 0.01). The subjects with long‐term HAART were found to have a greater risk of having oral lesions than those with short‐term HAART ( P  < 0.05). The unstimulated and stimulated salivary flow rates of the subjects with HAART were significantly lower than in those without HAART ( P  < 0.05). Conclusion:  We conclude that long‐term HAART has adverse effects on oral health status of HIV‐infected subjects.
The aim of this study was to determine the effects of long-term use of highly active antiretroviral therapy (HAART) on oral health status of HIV-infected subjects.BACKGROUNDThe aim of this study was to determine the effects of long-term use of highly active antiretroviral therapy (HAART) on oral health status of HIV-infected subjects.Oral examination and measurement of saliva flow rate of both unstimulated and wax-stimulated whole saliva were performed in HIV-infected subjects with and without HAART, and in non-HIV individuals. The following data were recorded; duration and risk of HIV infection, type and duration of HAART, CD4 cell count, viral load, presence of orofacial pain, oral dryness, oral burning sensation, oral lesions, cervical caries, and periodontal pocket. Multiple logistic regression analysis was performed to determine the effects of long-term use of HAART on oral health status of HIV-infected subjects.METHODSOral examination and measurement of saliva flow rate of both unstimulated and wax-stimulated whole saliva were performed in HIV-infected subjects with and without HAART, and in non-HIV individuals. The following data were recorded; duration and risk of HIV infection, type and duration of HAART, CD4 cell count, viral load, presence of orofacial pain, oral dryness, oral burning sensation, oral lesions, cervical caries, and periodontal pocket. Multiple logistic regression analysis was performed to determine the effects of long-term use of HAART on oral health status of HIV-infected subjects.One hundred and fifty-seven HIV-infected subjects - 99 on HAART (age range 23-57 years, mean 39 years) and 58 not on HAART (age range 20-59 years, mean 34 years) - and 50 non-HIV controls (age range 19-59 years, mean 36 years) were enrolled. The most common HAART regimen was 2 NRTI + 2 NNRTI. HIV-infected subjects without HAART showed greater risks of having orofacial pain, oral dryness, oral lesions, and periodontal pockets than those with short-term HAART (P < 0.01). The subjects with long-term HAART were found to have a greater risk of having oral lesions than those with short-term HAART (P < 0.05). The unstimulated and stimulated salivary flow rates of the subjects with HAART were significantly lower than in those without HAART (P < 0.05).RESULTSOne hundred and fifty-seven HIV-infected subjects - 99 on HAART (age range 23-57 years, mean 39 years) and 58 not on HAART (age range 20-59 years, mean 34 years) - and 50 non-HIV controls (age range 19-59 years, mean 36 years) were enrolled. The most common HAART regimen was 2 NRTI + 2 NNRTI. HIV-infected subjects without HAART showed greater risks of having orofacial pain, oral dryness, oral lesions, and periodontal pockets than those with short-term HAART (P < 0.01). The subjects with long-term HAART were found to have a greater risk of having oral lesions than those with short-term HAART (P < 0.05). The unstimulated and stimulated salivary flow rates of the subjects with HAART were significantly lower than in those without HAART (P < 0.05).We conclude that long-term HAART has adverse effects on oral health status of HIV-infected subjects.CONCLUSIONWe conclude that long-term HAART has adverse effects on oral health status of HIV-infected subjects.
J Oral Pathol Med (2010) 39: 397–406 Background:  The aim of this study was to determine the effects of long‐term use of highly active antiretroviral therapy (HAART) on oral health status of HIV‐infected subjects. Methods:  Oral examination and measurement of saliva flow rate of both unstimulated and wax‐stimulated whole saliva were performed in HIV‐infected subjects with and without HAART, and in non‐HIV individuals. The following data were recorded; duration and risk of HIV infection, type and duration of HAART, CD4 cell count, viral load, presence of orofacial pain, oral dryness, oral burning sensation, oral lesions, cervical caries, and periodontal pocket. Multiple logistic regression analysis was performed to determine the effects of long‐term use of HAART on oral health status of HIV‐infected subjects. Results:  One hundred and fifty‐seven HIV‐infected subjects – 99 on HAART (age range 23–57 years, mean 39 years) and 58 not on HAART (age range 20–59 years, mean 34 years) – and 50 non‐HIV controls (age range 19–59 years, mean 36 years) were enrolled. The most common HAART regimen was 2 NRTI + 2 NNRTI. HIV‐infected subjects without HAART showed greater risks of having orofacial pain, oral dryness, oral lesions, and periodontal pockets than those with short‐term HAART (P < 0.01). The subjects with long‐term HAART were found to have a greater risk of having oral lesions than those with short‐term HAART (P < 0.05). The unstimulated and stimulated salivary flow rates of the subjects with HAART were significantly lower than in those without HAART (P < 0.05). Conclusion:  We conclude that long‐term HAART has adverse effects on oral health status of HIV‐infected subjects.
J Oral Pathol Med (2010) 39: 397-406Background: The aim of this study was to determine the effects of long-term use of highly active antiretroviral therapy (HAART) on oral health status of HIV-infected subjects.Methods: Oral examination and measurement of saliva flow rate of both unstimulated and wax-stimulated whole saliva were performed in HIV-infected subjects with and without HAART, and in non-HIV individuals. The following data were recorded; duration and risk of HIV infection, type and duration of HAART, CD4 cell count, viral load, presence of orofacial pain, oral dryness, oral burning sensation, oral lesions, cervical caries, and periodontal pocket. Multiple logistic regression analysis was performed to determine the effects of long-term use of HAART on oral health status of HIV-infected subjects.Results: One hundred and fifty-seven HIV-infected subjects - 99 on HAART (age range 23-57 years, mean 39 years) and 58 not on HAART (age range 20-59 years, mean 34 years) - and 50 non-HIV controls (age range 19-59 years, mean 36 years) were enrolled. The most common HAART regimen was 2 NRTI + 2 NNRTI. HIV-infected subjects without HAART showed greater risks of having orofacial pain, oral dryness, oral lesions, and periodontal pockets than those with short-term HAART (P < 0.01). The subjects with long-term HAART were found to have a greater risk of having oral lesions than those with short-term HAART (P < 0.05). The unstimulated and stimulated salivary flow rates of the subjects with HAART were significantly lower than in those without HAART (P < 0.05).Conclusion: We conclude that long-term HAART has adverse effects on oral health status of HIV-infected subjects.
The aim of this study was to determine the effects of long-term use of highly active antiretroviral therapy (HAART) on oral health status of HIV-infected subjects. Oral examination and measurement of saliva flow rate of both unstimulated and wax-stimulated whole saliva were performed in HIV-infected subjects with and without HAART, and in non-HIV individuals. The following data were recorded; duration and risk of HIV infection, type and duration of HAART, CD4 cell count, viral load, presence of orofacial pain, oral dryness, oral burning sensation, oral lesions, cervical caries, and periodontal pocket. Multiple logistic regression analysis was performed to determine the effects of long-term use of HAART on oral health status of HIV-infected subjects. One hundred and fifty-seven HIV-infected subjects - 99 on HAART (age range 23-57 years, mean 39 years) and 58 not on HAART (age range 20-59 years, mean 34 years) - and 50 non-HIV controls (age range 19-59 years, mean 36 years) were enrolled. The most common HAART regimen was 2 NRTI + 2 NNRTI. HIV-infected subjects without HAART showed greater risks of having orofacial pain, oral dryness, oral lesions, and periodontal pockets than those with short-term HAART (P < 0.01). The subjects with long-term HAART were found to have a greater risk of having oral lesions than those with short-term HAART (P < 0.05). The unstimulated and stimulated salivary flow rates of the subjects with HAART were significantly lower than in those without HAART (P < 0.05). We conclude that long-term HAART has adverse effects on oral health status of HIV-infected subjects.
Author Nittayananta, Wipawee
Silpapojakul, Kachornsakdi
Talungchit, Sineepat
Pruphetkaew, Nannapat
Nilmanat, Ampaipith
Chayakul, Panthip
Jaruratanasirikul, Sutep
AuthorAffiliation 1 Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand
2 Department of Oral Surgery and Oral Medicine, Faculty of Dentistry, Srinakharinwirot University, Bangkok, Thailand
4 Division of Medicine, Hat Yai Regional Hospital, Hat Yai, Thailand
3 Department of Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand
AuthorAffiliation_xml – name: 4 Division of Medicine, Hat Yai Regional Hospital, Hat Yai, Thailand
– name: 2 Department of Oral Surgery and Oral Medicine, Faculty of Dentistry, Srinakharinwirot University, Bangkok, Thailand
– name: 1 Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand
– name: 3 Department of Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand
Author_xml – sequence: 1
  givenname: Wipawee
  surname: Nittayananta
  fullname: Nittayananta, Wipawee
  organization: Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand
– sequence: 2
  givenname: Sineepat
  surname: Talungchit
  fullname: Talungchit, Sineepat
  organization: Department of Oral Surgery and Oral Medicine, Faculty of Dentistry, Srinakharinwirot University, Bangkok, Thailand
– sequence: 3
  givenname: Sutep
  surname: Jaruratanasirikul
  fullname: Jaruratanasirikul, Sutep
  organization: Department of Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand
– sequence: 4
  givenname: Kachornsakdi
  surname: Silpapojakul
  fullname: Silpapojakul, Kachornsakdi
  organization: Department of Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand
– sequence: 5
  givenname: Panthip
  surname: Chayakul
  fullname: Chayakul, Panthip
  organization: Department of Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand
– sequence: 6
  givenname: Ampaipith
  surname: Nilmanat
  fullname: Nilmanat, Ampaipith
  organization: Division of Medicine, Hat Yai Regional Hospital, Hat Yai, Thailand
– sequence: 7
  givenname: Nannapat
  surname: Pruphetkaew
  fullname: Pruphetkaew, Nannapat
  organization: Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20202089$$D View this record in MEDLINE/PubMed
BookMark eNqNkUtv1DAUhS1URKeFv4C8Y5Vw_UicSAhpqEqn0JfKAEvLceyOh0xc4gSm_564UwKsqL2wZX_n-F6fA7TX-tYghAmkZByv1ynJARIQhKcUoEwBCpGl2ydoNl3soRmUwBOaEbqPDkJYAxDBOHmG9inEWZQzdHVsrdF9wN7ixrc3SW-6DR6CiQeL-fx6iX2LfacavDKq6Vc49Kof7vnF6ZfEtVFuahyGah2NnqOnVjXBvHhYD9Hn98fLo0VydnlyejQ_S3SWFVnCS2s51zmpa2Hz2maMcmKVBmCi4lUFlBUlr3IjbKaJ4sSAqhgYVenCatDsEL3d-d4O1cbU2rT9WKS87dxGdXfSKyf_vWndSt74H5JRIiijo8GrB4POfx9M6OXGBW2aRrXGD0EKzvNSUFH8n2SMFpSXkXz5d1FTNb__ewSKHaA7H0Jn7IQQkDFauZYxQRkTlDFaeR-t3P5peJJqN0bhfGzPNY8xeLMz-Okac_foh-WHy6txM8qTndyF3mwnueq-yVywkfx6cSLfwbK4Pucf5Sf2C7jWy7w
CitedBy_id crossref_primary_10_1111_adj_12031
crossref_primary_10_1155_2024_5559610
crossref_primary_10_1111_bcp_12363
crossref_primary_10_1111_jicd_12142
crossref_primary_10_4103_jfmpc_jfmpc_1191_21
crossref_primary_10_1186_s12903_019_0847_9
crossref_primary_10_3390_ijms19092747
crossref_primary_10_1016_j_adaj_2020_04_013
crossref_primary_10_1111_j_1600_0714_2011_01117_x
crossref_primary_10_1111_jop_12023
crossref_primary_10_1111_prd_12321
crossref_primary_10_1186_1471_2180_12_153
crossref_primary_10_1111_jop_12304
crossref_primary_10_1111_jcpe_13735
crossref_primary_10_1111_hiv_12475
crossref_primary_10_1111_jicd_12351
crossref_primary_10_1186_s12879_024_09050_4
crossref_primary_10_1186_s12879_024_09594_5
crossref_primary_10_1038_sj_bdj_2010_742
crossref_primary_10_2169_internalmedicine_8409_16
crossref_primary_10_1016_j_jksus_2022_102010
crossref_primary_10_2174_1570162X20666211227154558
crossref_primary_10_15311_selcukdentj_1146073
crossref_primary_10_1111_odi_12093
crossref_primary_10_1111_jphd_12336
crossref_primary_10_4103_jispcd_JISPCD_229_21
crossref_primary_10_1111_odi_12135
crossref_primary_10_1159_000357273
crossref_primary_10_1089_aid_2012_0359
crossref_primary_10_1111_j_1600_0714_2012_01183_x
crossref_primary_10_5005_jp_journals_10024_2209
crossref_primary_10_1111_odi_12411
crossref_primary_10_4103_jfmpc_jfmpc_1032_20
crossref_primary_10_1111_odi_12412
crossref_primary_10_4103_JMAU_JMAU_32_19
crossref_primary_10_1186_s12903_023_03821_2
crossref_primary_10_2105_AJPH_2014_301871
crossref_primary_10_1155_2011_964278
crossref_primary_10_5005_jp_journals_10062_0096
crossref_primary_10_1038_s41415_022_4040_1
crossref_primary_10_1111_odi_13470
crossref_primary_10_1128_spectrum_00871_23
crossref_primary_10_1007_s11904_013_0191_7
crossref_primary_10_1038_s41432_021_0209_8
crossref_primary_10_1007_s11136_022_03299_5
crossref_primary_10_1038_s41407_022_0958_z
crossref_primary_10_1111_j_1754_4505_2012_00247_x
crossref_primary_10_1111_odi_12103
crossref_primary_10_1155_2013_613278
crossref_primary_10_1111_odi_12424
crossref_primary_10_1007_s11095_016_2048_4
crossref_primary_10_1007_s11046_015_9874_5
crossref_primary_10_1080_09540121_2012_663884
crossref_primary_10_1111_j_1600_0714_2011_01089_x
crossref_primary_10_1902_jop_2011_110318
crossref_primary_10_1177_0022034516661518
crossref_primary_10_1186_s12903_018_0675_3
crossref_primary_10_1111_prd_12274
crossref_primary_10_1111_scd_12942
crossref_primary_10_53424_balikesirsbd_1139258
crossref_primary_10_1177_23800844221087951
crossref_primary_10_1111_j_1600_0757_2012_00445_x
Cites_doi 10.1086/338637
10.1023/A:1014443418737
10.1067/moe.2001.118902
10.1111/j.1600-0714.1993.tb01074.x
10.1016/S0966-842X(02)02330-2
10.1111/j.1601-0825.2006.01306_12.x
10.1086/381504
10.1016/S1079-2104(00)70092-8
10.2214/ajr.157.3.1651645
10.1089/108729100317920
10.1111/j.1600-0714.1990.tb00791.x
10.1097/00126334-199905010-00003
10.1111/j.1600-0714.1998.tb01936.x
10.1089/108729100750018317
10.1034/j.1600-0714.2000.290708.x
10.1017/S0022215100110990
10.1016/S1368-8375(98)00028-1
10.1177/154405910408301109
10.1034/j.1601-0825.2002.1o787.x
10.14219/jada.archive.1986.0321
10.1016/S0140-6736(97)04352-3
10.1111/j.1600-0714.1990.tb00832.x
10.1086/338445
10.1177/154405910408300212
10.1111/j.1600-0714.1992.tb00994.x
10.1080/19424396.2002.12223320
10.1016/S0140-6736(97)10291-4
10.1111/j.1601-0825.1999.tb00092.x
10.1034/j.1601-0825.2003.02868.x
10.1016/S0140-6736(00)04578-5
10.1016/0030-4220(94)90195-3
10.1097/QAI.0b013e3181967602
10.1111/j.1601-0825.2006.01232.x
10.1086/423181
10.1046/j.1601-0825.2003.00994.x
10.1097/00005792-200301000-00004
10.1097/00002030-200102002-00003
10.1001/jama.300.5.555
10.1016/0190-9622(90)70039-K
10.7326/0003-4819-112-1-3
10.1111/j.1600-0714.2007.00598.x
10.1177/00220345820610100901
10.1016/j.tripleo.2005.07.021
10.1067/moe.2002.126025
10.1177/00220345000790071201
10.1177/154405910308200912
10.1016/0896-8411(89)90170-4
10.1007/s11904-008-0002-8
10.1111/j.1834-7819.1996.tb05652.x
10.1016/S1079-2104(99)70242-8
10.7326/0003-4819-134-9_Part_2-200105011-00009
10.1034/j.1600-0714.2002.310101.x
10.1111/j.1752-7325.2003.tb03480.x
10.1034/j.1601-0825.2001.70401.x
10.1111/j.1601-0825.2008.01456.x
10.1136/ard.57.12.749
10.1056/NEJM199508173330710
10.1089/10872910050206540
10.1067/moe.2003.230
10.1159/000330987
10.1001/jama.280.1.72
ContentType Journal Article
Copyright 2010 John Wiley & Sons A/S
2010 John Wiley & Sons A/S · All rights reserved 2010
Copyright_xml – notice: 2010 John Wiley & Sons A/S
– notice: 2010 John Wiley & Sons A/S · All rights reserved 2010
DBID BSCLL
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7U9
H94
5PM
DOI 10.1111/j.1600-0714.2009.00875.x
DatabaseName Istex
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Virology and AIDS Abstracts
DatabaseTitleList CrossRef
MEDLINE - Academic

AIDS and Cancer Research Abstracts
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Dentistry
EISSN 1600-0714
EndPage 406
ExternalDocumentID PMC3217232
20202089
10_1111_j_1600_0714_2009_00875_x
JOP875
ark_67375_WNG_B0T8RM4K_S
Genre article
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations Thailand
GeographicLocations_xml – name: Thailand
GrantInformation_xml – fundername: NIDCR NIH HHS
  grantid: R21 DE018340
– fundername: NIDCR NIH HHS
  grantid: R21-DE-018340
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
1OB
1OC
29L
31~
33P
34H
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAKAS
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZCM
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHEFC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
CWXXS
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
UDS
V8K
W8V
W99
WBKPD
WBNRW
WIH
WIJ
WIK
WOHZO
WPGGZ
WQJ
WRC
WXI
WXSBR
X7M
XG1
YFH
YOC
YUY
ZGI
ZXP
ZZTAW
~IA
~WT
AAHQN
AAIPD
AAMNL
AANHP
AAYCA
ACRPL
ACYXJ
ADNMO
AFWVQ
ALVPJ
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
7U9
H94
5PM
ID FETCH-LOGICAL-c5585-49ff44c61dd7f6df53241fac0037b4bb023894b6e7f5c1a41e0ab30eabc8fc0c3
IEDL.DBID DR2
ISSN 0904-2512
1600-0714
IngestDate Thu Aug 21 18:36:42 EDT 2025
Fri Jul 11 06:25:01 EDT 2025
Fri Jul 11 05:09:41 EDT 2025
Sat May 31 02:10:54 EDT 2025
Thu Apr 24 22:57:46 EDT 2025
Tue Jul 01 00:50:51 EDT 2025
Wed Jan 22 16:43:07 EST 2025
Wed Oct 30 10:01:36 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5585-49ff44c61dd7f6df53241fac0037b4bb023894b6e7f5c1a41e0ab30eabc8fc0c3
Notes ArticleID:JOP875
istex:9E76685591FFA5BD86433D623D94158C72EC90D2
ark:/67375/WNG-B0T8RM4K-S
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
PMID 20202089
PQID 733282498
PQPubID 23479
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3217232
proquest_miscellaneous_744697278
proquest_miscellaneous_733282498
pubmed_primary_20202089
crossref_primary_10_1111_j_1600_0714_2009_00875_x
crossref_citationtrail_10_1111_j_1600_0714_2009_00875_x
wiley_primary_10_1111_j_1600_0714_2009_00875_x_JOP875
istex_primary_ark_67375_WNG_B0T8RM4K_S
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate May 2010
PublicationDateYYYYMMDD 2010-05-01
PublicationDate_xml – month: 05
  year: 2010
  text: May 2010
PublicationDecade 2010
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Denmark
PublicationTitle Journal of oral pathology & medicine
PublicationTitleAlternate J Oral Pathol Med
PublicationYear 2010
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References Silvermann S Jr, Migliorati CA, Lozada-Nur F, Greenspan D, Conant MA. Oral findings in people with or at a high risk for AIDS; a study of 375 homosexual males. J Am Dent Assoc 1986; 112: 187-92.
Greenspan D, Gange SJ, Phelan JA, et al. Incidence of oral lesions in HIV-1 infected women: reduction with HAART. J Dent Res 2004; 83: 145-50.
Lin AL, Johnson DA, Stephan KT, Yeh CK. Alteration in salivary function in early HIV infection. J Dent Res 2003; 82: 719-24.
Diz Dios P, Ocampo A, Miralles C, Otero I, Iglesias I, Rayo N. Frequency of oropharyngeal candidiasis in HIV-infected patients on protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 87: 437-41.
Poizot-Martin I, Lafeuillade A, Dhiver C, et al. Cutaneo-mucosal hyperpigmentation in AIDS. 4 cases [in French]. Presse Med 1991; 20: 632-6.
Phelan JA, Mulligan R, Nelson E, et al. Dental caries in HIV-seropositive women. J Dent Res 2004; 83: 869-73.
Greenwood I, Zakrzewska JM, Robinson PG. Changes in the prevalence of HIV-associated mucosal disease at a dedicated clinic over 7 years. Oral Dis 2002; 8: 90-4.
Ho DD. Time to hit HIV, early and hard. N Engl J Med 1995; 333: 450-1.
Cassone A, Tacconelli E, De Bernardis F, et al. Antiretroviral therapy with protease inhibitors has an early, immune reconstitution-independent beneficial effect on Candida virulence and oral candidiasis in human immunodeficiency virus-infected subjects. J Infect Dis 2002; 185: 188-95.
Ramirez V, Gonzalez A, De La Rosa E, et al. Oral lesions in Mexican HIV-infected patients. J Oral Pathol Med 1990; 19: 482-5.
Mandel L, Surattanont F. Regression of HIV parotid swellings after antiviral therapy: case reports with computed tomographic scan evidence. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 94: 454-9.
Race EM, Adelson-Mitty J, Kriegel GR, et al. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease. Lancet 1998; 351: 252-5.
Coates E, Slade GD, Goss AN, Gorkic E. Oral conditions and their social impact among HIV dental patients. Aust Dent J 1996; 41: 33-6.
Baqui AA, Meiller T, Jabra-Rizk M, Zhang M, Kelley J, Falkler W. Association of HIV viral load with oral diseases. Oral Dis 1999; 5: 294-8.
Lederman MM. Immune restoration and CD4+ T-cell function with antiretroviral therapies. AIDS 2001; 15(Suppl. 2): S11-5.
Navazesh M, Mulligan R, Karim R, et al. Effect of HAART on salivary gland function in the Women's Interagency HIV Study (WIHS). Oral Dis 2009; 15: 52-60.
Li TS, Tubiana R, Katlama C, Calvez V, Ait Mohand H, Autran B. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 1998; 351: 1682-6.
Bretz WA, Flaitz C, Moretti A, Corby P, Schneider LG, Nichols CM. Medication usage and dental caries outcome-related variables in HIV/AIDS patients. AIDS Patient Care STDs 2000; 14: 549-54.
Uccini S, D'Offizi G, Angelici A, et al. Cystic lymphoepithelial lesions of the parotid gland in HIV-1 infection. AIDS Patient Care STDs 2000; 14: 143-7.
Coulter ID, Heslin KC, Marcus M, et al. Associations of self-reported oral health with physical and mental health in a nationally representative sample of HIV persons receiving medical care. Qual Life Res 2002; 11: 57-70.
Bruner JM, Cleary KR, Smith FB, Batsakis JG. Immunocytochemical identification of HIV (p24) antigen in parotid lymphoid lesions. J Laryngol Otol 1989; 103: 1063-6.
Kreimer AR, Alberg AJ, Daniel R, et al. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis 2004; 189: 686-98.
Nittayananta W, Chungpanich S. Oral lesions in a group of Thai people with AIDS. Oral Dis 1997; 3(Suppl. 1): 1-5.
Miziara ID, Weber R. Oral lesions as predictors of highly active antiretroviral therapy failure in Brazilian HIV-infected children. J Oral Pathol Med 2008; 37: 99-106.
Lin AL, Johnson DA, Sims CA, Stephan KT, Yeh CK. Salivary gland function in HIV-infected patients treated with highly active antiretroviral therapy (HAART). Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102: 318-24.
Ceballos-Salobrena A, Gaitan-Cepeda LA, Ceballos-Garcia L, Lezama-Del Valle D. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS? AIDS Patient Care STDS 2000; 14: 627-35.
Nittayananta W, Chanowanna N, Jealae S, Nauntofte B, Stoltze K. Hyposalivation, xerostomia and oral health status of HIV-infected subjects in Thailand before HAART era. J Oral Pathol Med 2009 (in press).
Schiodt M, Greenspan D, Daniels TE, et al. Parotid gland enlargement and xerostomia associated with labial sialadenitis in HIV-infected patients. J Autoimmun 1989; 2: 415-25.
Laskaris G, Hadjivassiliou M, Stratigos J. Oral signs and symptoms in 160 Greek HIV-infected patients. J Oral Pathol Med 1992; 21: 120-3.
Nicolatou-Galitis O, Velegraki A, Paikos S, et al. Effect of PI-HAART on the prevalence of oral lesions in HIV-I infected patients. A Greek study. Oral Dis 2004; 10: 145-50.
Vicandi B, Jimenez-Heffernan JA, Lopez-Ferrer P, et al. HIV-1 (p24)-positive multinucleated giant cells in HIV-associated lymphoepithelial lesion of the parotid gland. A report of two cases. Acta Cytol 1999; 43: 247-51.
Bendick C, Scheifele C, Reichart PA. Oral manifestations in 101 Cambodians with HIV and AIDS. J Oral Pathol Med 2002; 31: 1-4.
Soberman N, Leonidas JC, Berdon WE, et al. Parotid enlargement in children seropositive for human immunodeficiency virus: imaging findings. AJR Am J Roentgenol 1991; 157: 553-6.
Patton LL, McKaig R, Strauss R, Rogers D, Eron JJ Jr. Changing prevalence of oral manifestations of human immune-deficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 89: 299-304.
Munro CA, Hube B. Anti-fungal therapy at the HAART of viral therapy. Trends Microbiol 2002; 10: 173-7.
Navazesh M, Mulligan R, Barron Y, et al. A 4-year longitudinal evaluation of xerostomia and salivary gland hypofunction in the Women's Interagency HIV Study participants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95: 693-8.
Tappuni AR, Fleming GJ. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92: 623-8.
Arendorf TM, Bredekamp B, Cloete CA, Sauer G. Oral manifestations of HIV infection in 600 South African patients. J Oral Pathol Med 1998; 27: 176-9.
Greenspan D, Canchola AJ, MacPhail LA, Cheikh B, Greenspan JS. Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet 2001; 357: 1411-2.
King MD, Reznik DA, O'Daniels CM, Larsen NM, Osterholt D, Blumberg HM. Human papillomavirus-associated oral warts among human immunodeficiency virus-seropositive patients in the era of highly active antiretroviral therapy: an emerging infection. Clin Infect Dis 2002; 34: 641-8.
Nokta M. Oral manifestations associated with HIV infection. Curr HIV/AIDS Rep 2008; 5: 5-12.
Itescu S, Brancato LJ, Buxbaum J, et al. A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA-DR5. Ann Intern Med 1990; 112: 3-10.
Navazesh M, Mulligan R, Komaroff E, Redford M, Greenspan D, Phelan J. The prevalence of xerostomia and salivary gland hypofunction in a cohort of HIV-positive and at-risk women. J Dent Res 2000; 79: 1502-7.
C'Decosta J, Saranath D, Dedhia P, Sanghvi V, Mehta AR. Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol 1998; 34: 413-20.
Lorenz KA, Shapiro MF, Asch SM, Bozzette SA, Hays RD. Associations of symptoms and health-related quality of life: findings from a national study of persons with HIV infection. Ann Intern Med 2001; 134: 854-60.
Silverberg MJ, Gore ME, French AL, et al. Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study. Clin Infect Dis 2004; 39: 717-24.
Tukutuku K, Muyembe-Tamfum L, Kayembe K, Odio W, Kandi K, Ntumba M. Oral manifestations of AIDS in a heterosexual population in a Zaire hospital. J Oral Pathol Med 1990; 19: 232-4.
Powderly WG, Landay A, Lederman MM. Recovery of the immune system with antiretroviral therapy: the end of opportunism? J Am Med Assoc 1998; 280: 72-7.
Chasombat S, McConnell MS, Siangphoe U, et al. National expansion of antiretroviral treatment in Thailand, 2000-2007: program scale-up and patient outcomes. J Acquir Immune Defic Syndr 2009; 50: 506-12.
Sharma G, Pai KM, Suhas S, Ramapuram JT, Doshi D, Anup N. Oral manifestations in HIV/AIDS infected patients from India. Oral Dis 2006; 12: 537-42.
Olive A, Salavert A, Manriquez M, Clotet B, Moragas A. Parotid lipomatosis in HIV positive patients: a new clinical disorder associated with protease inhibitors. Ann Rheum Dis 1998; 57: 749.
Ramos-Gomez FJ, Flaitz C, Catapano P, Murray P, Milnes AR, Dorenbaum A. Classification, diagnostic criteria, and treatment recommendations for orofacial manifestations in HIV-infected pediatric patients. Collaborative Workgroup on Oral Manifestations of Pediatric HIV Infection. J Clin Pediatr Dent 1999; 23: 85-96.
Cauda R, Tacconelli E, Tumbarello M, et al. Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study. J Acquir Immune Defic Syndr 1999; 21: 20-5.
Zakrzewska JM, Atkin PA. Oral mucosal lesions in a UK HIV/AIDS oral medicine clinic. A nine year, cross-sectional, prospective study. Oral Health Prev Dent 2003; 1: 73-9.
Greenberg RG, Berger TG. Nail and mucocutaneous hyperpigmentation with azidothymidine therapy. J Am Acad Dermatol 1990; 22: 327-30.
Schmidt-Westhausen AM, Priepke F, Bergmann FJ, Reichart PA. Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy. J Oral Pathol Med 2000; 29:
2001; 92
1998; 280
1991; 157
2000; 89
2002; 94
1990; 19
1993; 22
2002; 10
2002; 11
2008; 37
1999; 87
1999; 43
2008; 5
1995; 333
2008; 300
1997; 3
2003; 95
1998; 351
2001; 134
2000; 14
2009; 50
1982; 61
1989; 103
2002; 185
2004; 39
2003; 9
1994; 77
2001; 15
2003; 1
2003; 82
2009; 15
1998; 57
2004; 189
1998; 27
1989; 2
2000; 29
2004; 83
2006; 12
2002; 30
2002; 31
1986; 112
2002; 34
2002; 8
2009
1999; 23
1999; 21
1999; 5
2004; 10
1990; 22
2001; 7
2000; 79
1991; 20
1996; 41
1990; 112
1992; 21
2003; 63
2001; 357
1998; 34
1998; 77
2006; 102
e_1_2_6_51_2
e_1_2_6_53_2
e_1_2_6_30_2
e_1_2_6_19_2
e_1_2_6_13_2
e_1_2_6_59_2
e_1_2_6_32_2
e_1_2_6_17_2
e_1_2_6_38_2
e_1_2_6_55_2
e_1_2_6_15_2
e_1_2_6_36_2
e_1_2_6_57_2
e_1_2_6_62_2
e_1_2_6_64_2
Zakrzewska JM (e_1_2_6_39_2) 2003; 1
e_1_2_6_41_2
e_1_2_6_60_2
e_1_2_6_7_2
e_1_2_6_9_2
e_1_2_6_3_2
e_1_2_6_5_2
e_1_2_6_24_2
e_1_2_6_47_2
e_1_2_6_22_2
e_1_2_6_49_2
Nittayananta W (e_1_2_6_20_2) 2009
e_1_2_6_28_2
e_1_2_6_43_2
e_1_2_6_66_2
e_1_2_6_26_2
e_1_2_6_45_2
e_1_2_6_68_2
Glick M (e_1_2_6_50_2) 1998; 77
e_1_2_6_52_2
e_1_2_6_31_2
e_1_2_6_18_2
Ramos‐Gomez FJ (e_1_2_6_21_2) 1999; 23
e_1_2_6_12_2
e_1_2_6_35_2
e_1_2_6_58_2
e_1_2_6_10_2
e_1_2_6_33_2
e_1_2_6_16_2
e_1_2_6_54_2
e_1_2_6_14_2
e_1_2_6_37_2
e_1_2_6_56_2
Navazesh M (e_1_2_6_61_2) 2002; 30
Nittayananta W (e_1_2_6_11_2) 1997; 3
e_1_2_6_63_2
e_1_2_6_42_2
e_1_2_6_40_2
e_1_2_6_8_2
e_1_2_6_29_2
e_1_2_6_4_2
e_1_2_6_6_2
e_1_2_6_23_2
Poizot‐Martin I (e_1_2_6_34_2) 1991; 20
e_1_2_6_48_2
e_1_2_6_2_2
e_1_2_6_65_2
e_1_2_6_27_2
e_1_2_6_44_2
e_1_2_6_67_2
e_1_2_6_25_2
e_1_2_6_46_2
References_xml – reference: Li TS, Tubiana R, Katlama C, Calvez V, Ait Mohand H, Autran B. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 1998; 351: 1682-6.
– reference: Cauda R, Tacconelli E, Tumbarello M, et al. Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study. J Acquir Immune Defic Syndr 1999; 21: 20-5.
– reference: Greenwood I, Zakrzewska JM, Robinson PG. Changes in the prevalence of HIV-associated mucosal disease at a dedicated clinic over 7 years. Oral Dis 2002; 8: 90-4.
– reference: Bendick C, Scheifele C, Reichart PA. Oral manifestations in 101 Cambodians with HIV and AIDS. J Oral Pathol Med 2002; 31: 1-4.
– reference: Poizot-Martin I, Lafeuillade A, Dhiver C, et al. Cutaneo-mucosal hyperpigmentation in AIDS. 4 cases [in French]. Presse Med 1991; 20: 632-6.
– reference: Miziara ID, Weber R. Oral lesions as predictors of highly active antiretroviral therapy failure in Brazilian HIV-infected children. J Oral Pathol Med 2008; 37: 99-106.
– reference: Navazesh M, Mulligan R, Karim R, et al. Effect of HAART on salivary gland function in the Women's Interagency HIV Study (WIHS). Oral Dis 2009; 15: 52-60.
– reference: Silvermann S Jr, Migliorati CA, Lozada-Nur F, Greenspan D, Conant MA. Oral findings in people with or at a high risk for AIDS; a study of 375 homosexual males. J Am Dent Assoc 1986; 112: 187-92.
– reference: Sharma G, Pai KM, Suhas S, Ramapuram JT, Doshi D, Anup N. Oral manifestations in HIV/AIDS infected patients from India. Oral Dis 2006; 12: 537-42.
– reference: Greenberg RG, Berger TG. Nail and mucocutaneous hyperpigmentation with azidothymidine therapy. J Am Acad Dermatol 1990; 22: 327-30.
– reference: Bruner JM, Cleary KR, Smith FB, Batsakis JG. Immunocytochemical identification of HIV (p24) antigen in parotid lymphoid lesions. J Laryngol Otol 1989; 103: 1063-6.
– reference: Lederman MM. Immune restoration and CD4+ T-cell function with antiretroviral therapies. AIDS 2001; 15(Suppl. 2): S11-5.
– reference: Ho DD. Time to hit HIV, early and hard. N Engl J Med 1995; 333: 450-1.
– reference: Lin AL, Johnson DA, Stephan KT, Yeh CK. Alteration in salivary function in early HIV infection. J Dent Res 2003; 82: 719-24.
– reference: Olive A, Salavert A, Manriquez M, Clotet B, Moragas A. Parotid lipomatosis in HIV positive patients: a new clinical disorder associated with protease inhibitors. Ann Rheum Dis 1998; 57: 749.
– reference: Reichart P. US1 HIV - changing patterns in HAART era, patients' quality of life and occupational risks. Oral Dis 2006; 12(Suppl. 1): 3.
– reference: Zakrzewska JM, Atkin PA. Oral mucosal lesions in a UK HIV/AIDS oral medicine clinic. A nine year, cross-sectional, prospective study. Oral Health Prev Dent 2003; 1: 73-9.
– reference: Navazesh M, Mulligan R, Komaroff E, Redford M, Greenspan D, Phelan J. The prevalence of xerostomia and salivary gland hypofunction in a cohort of HIV-positive and at-risk women. J Dent Res 2000; 79: 1502-7.
– reference: Coates E, Slade GD, Goss AN, Gorkic E. Oral conditions and their social impact among HIV dental patients. Aust Dent J 1996; 41: 33-6.
– reference: Schiodt M, Greenspan D, Daniels TE, et al. Parotid gland enlargement and xerostomia associated with labial sialadenitis in HIV-infected patients. J Autoimmun 1989; 2: 415-25.
– reference: EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Human Immunodeficiency Virus. Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med 1993; 22: 289-91.
– reference: Patton LL, McKaig R, Strauss R, Rogers D, Eron JJ Jr. Changing prevalence of oral manifestations of human immune-deficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 89: 299-304.
– reference: Greenspan D, Gange SJ, Phelan JA, et al. Incidence of oral lesions in HIV-1 infected women: reduction with HAART. J Dent Res 2004; 83: 145-50.
– reference: Ceballos-Salobrena A, Gaitan-Cepeda LA, Ceballos-Garcia L, Lezama-Del Valle D. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS? AIDS Patient Care STDS 2000; 14: 627-35.
– reference: Munro CA, Hube B. Anti-fungal therapy at the HAART of viral therapy. Trends Microbiol 2002; 10: 173-7.
– reference: Silverberg MJ, Gore ME, French AL, et al. Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study. Clin Infect Dis 2004; 39: 717-24.
– reference: Glick M, Muzyka BC, Lurie D, et al. Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS. Oral Surg Oral Med Oral Pathol 1994; 77: 344-9.
– reference: Hammer SM, Eron JJ Jr, Reiss P, et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the international AIDS society USA panel. JAMA 2008; 300: 555-70.
– reference: Uccini S, D'Offizi G, Angelici A, et al. Cystic lymphoepithelial lesions of the parotid gland in HIV-1 infection. AIDS Patient Care STDs 2000; 14: 143-7.
– reference: Glick M, Berthold P, Danik J. Severe caries and the use of protease inhibitors (abstract). J Dent Res 1998; 77(Spec Iss): 84.
– reference: Navazesh M, Christensen CM. A comparison of whole mouth resting and stimulated salivary measurements procedures. J Dent Res 1982; 61: 1158-62.
– reference: Lorenz KA, Shapiro MF, Asch SM, Bozzette SA, Hays RD. Associations of symptoms and health-related quality of life: findings from a national study of persons with HIV infection. Ann Intern Med 2001; 134: 854-60.
– reference: Kreimer AR, Alberg AJ, Daniel R, et al. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis 2004; 189: 686-98.
– reference: Navazesh M, Denny P, Sobel S. Saliva: a fountain of opportunity. J Calif Dent Assoc 2002; 30: 783-8.
– reference: Arendorf TM, Bredekamp B, Cloete CA, Sauer G. Oral manifestations of HIV infection in 600 South African patients. J Oral Pathol Med 1998; 27: 176-9.
– reference: Ramos-Gomez FJ, Flaitz C, Catapano P, Murray P, Milnes AR, Dorenbaum A. Classification, diagnostic criteria, and treatment recommendations for orofacial manifestations in HIV-infected pediatric patients. Collaborative Workgroup on Oral Manifestations of Pediatric HIV Infection. J Clin Pediatr Dent 1999; 23: 85-96.
– reference: Diz Dios P, Ocampo A, Miralles C, Otero I, Iglesias I, Rayo N. Frequency of oropharyngeal candidiasis in HIV-infected patients on protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 87: 437-41.
– reference: C'Decosta J, Saranath D, Dedhia P, Sanghvi V, Mehta AR. Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol 1998; 34: 413-20.
– reference: Chasombat S, McConnell MS, Siangphoe U, et al. National expansion of antiretroviral treatment in Thailand, 2000-2007: program scale-up and patient outcomes. J Acquir Immune Defic Syndr 2009; 50: 506-12.
– reference: Nicolatou-Galitis O, Velegraki A, Paikos S, et al. Effect of PI-HAART on the prevalence of oral lesions in HIV-I infected patients. A Greek study. Oral Dis 2004; 10: 145-50.
– reference: Laskaris G, Hadjivassiliou M, Stratigos J. Oral signs and symptoms in 160 Greek HIV-infected patients. J Oral Pathol Med 1992; 21: 120-3.
– reference: Itescu S, Brancato LJ, Buxbaum J, et al. A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA-DR5. Ann Intern Med 1990; 112: 3-10.
– reference: Ramirez-Amador V, Esquivel-Pedraza L, Sierra-Madero J, Anaya-Saavedra G, Gonzalez-Ramirez L, Ponce-de-Leon S. The changing clinical spectrum of human immunodeficiency virus (HIV)-related oral lesions in 1000 consecutive patients: a 12-year study in a referral center in Mexico. Medicine (Baltimore) 2003; 82: 39-50.
– reference: Soberman N, Leonidas JC, Berdon WE, et al. Parotid enlargement in children seropositive for human immunodeficiency virus: imaging findings. AJR Am J Roentgenol 1991; 157: 553-6.
– reference: Nittayananta W, Chanowanna N, Jealae S, Nauntofte B, Stoltze K. Hyposalivation, xerostomia and oral health status of HIV-infected subjects in Thailand before HAART era. J Oral Pathol Med 2009 (in press).
– reference: Ramirez V, Gonzalez A, De La Rosa E, et al. Oral lesions in Mexican HIV-infected patients. J Oral Pathol Med 1990; 19: 482-5.
– reference: Schmidt-Westhausen AM, Priepke F, Bergmann FJ, Reichart PA. Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy. J Oral Pathol Med 2000; 29: 336-41.
– reference: Coulter ID, Heslin KC, Marcus M, et al. Associations of self-reported oral health with physical and mental health in a nationally representative sample of HIV persons receiving medical care. Qual Life Res 2002; 11: 57-70.
– reference: Cassone A, Tacconelli E, De Bernardis F, et al. Antiretroviral therapy with protease inhibitors has an early, immune reconstitution-independent beneficial effect on Candida virulence and oral candidiasis in human immunodeficiency virus-infected subjects. J Infect Dis 2002; 185: 188-95.
– reference: Greenspan D, Canchola AJ, MacPhail LA, Cheikh B, Greenspan JS. Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet 2001; 357: 1411-2.
– reference: King MD, Reznik DA, O'Daniels CM, Larsen NM, Osterholt D, Blumberg HM. Human papillomavirus-associated oral warts among human immunodeficiency virus-seropositive patients in the era of highly active antiretroviral therapy: an emerging infection. Clin Infect Dis 2002; 34: 641-8.
– reference: Phelan JA, Mulligan R, Nelson E, et al. Dental caries in HIV-seropositive women. J Dent Res 2004; 83: 869-73.
– reference: Patton LL, Strauss RP, McKaig RG, Porter DR, Eron JJ Jr. Perceived oral health status, unmet needs, and barriers to dental care among HIV/AIDS patients in a North Carolina cohort: impacts of race. J Public Health Dent 2003; 63: 86-91.
– reference: Tukutuku K, Muyembe-Tamfum L, Kayembe K, Odio W, Kandi K, Ntumba M. Oral manifestations of AIDS in a heterosexual population in a Zaire hospital. J Oral Pathol Med 1990; 19: 232-4.
– reference: Powderly WG, Landay A, Lederman MM. Recovery of the immune system with antiretroviral therapy: the end of opportunism? J Am Med Assoc 1998; 280: 72-7.
– reference: Baqui AA, Meiller T, Jabra-Rizk M, Zhang M, Kelley J, Falkler W. Association of HIV viral load with oral diseases. Oral Dis 1999; 5: 294-8.
– reference: Lin AL, Johnson DA, Sims CA, Stephan KT, Yeh CK. Salivary gland function in HIV-infected patients treated with highly active antiretroviral therapy (HAART). Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102: 318-24.
– reference: Navazesh M, Mulligan R, Barron Y, et al. A 4-year longitudinal evaluation of xerostomia and salivary gland hypofunction in the Women's Interagency HIV Study participants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95: 693-8.
– reference: Tappuni AR, Fleming GJ. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92: 623-8.
– reference: Race EM, Adelson-Mitty J, Kriegel GR, et al. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease. Lancet 1998; 351: 252-5.
– reference: Nokta M. Oral manifestations associated with HIV infection. Curr HIV/AIDS Rep 2008; 5: 5-12.
– reference: Scully C, Diz Dios P. Orofacial effects of antiretroviral therapies. Oral Dis 2001; 7: 205-10.
– reference: Nittayananta W, Chungpanich S. Oral lesions in a group of Thai people with AIDS. Oral Dis 1997; 3(Suppl. 1): 1-5.
– reference: Vargas PA, Mauad T, Bohm GM, Saldiva PH, Almeida OP. Parotid gland involvement in advanced AIDS. Oral Dis 2003; 9: 55-61.
– reference: Vicandi B, Jimenez-Heffernan JA, Lopez-Ferrer P, et al. HIV-1 (p24)-positive multinucleated giant cells in HIV-associated lymphoepithelial lesion of the parotid gland. A report of two cases. Acta Cytol 1999; 43: 247-51.
– reference: Mandel L, Surattanont F. Regression of HIV parotid swellings after antiviral therapy: case reports with computed tomographic scan evidence. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 94: 454-9.
– reference: Bretz WA, Flaitz C, Moretti A, Corby P, Schneider LG, Nichols CM. Medication usage and dental caries outcome-related variables in HIV/AIDS patients. AIDS Patient Care STDs 2000; 14: 549-54.
– volume: 77
  start-page: 84
  issue: Spec Iss
  year: 1998
  article-title: Severe caries and the use of protease inhibitors (abstract)
  publication-title: J Dent Res
– volume: 34
  start-page: 641
  year: 2002
  end-page: 8
  article-title: Human papillomavirus‐associated oral warts among human immunodeficiency virus‐seropositive patients in the era of highly active antiretroviral therapy: an emerging infection
  publication-title: Clin Infect Dis
– volume: 21
  start-page: 120
  year: 1992
  end-page: 3
  article-title: Oral signs and symptoms in 160 Greek HIV‐infected patients
  publication-title: J Oral Pathol Med
– volume: 95
  start-page: 693
  year: 2003
  end-page: 8
  article-title: A 4‐year longitudinal evaluation of xerostomia and salivary gland hypofunction in the Women’s Interagency HIV Study participants
  publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol Endod
– volume: 351
  start-page: 252
  year: 1998
  end-page: 5
  article-title: Focal mycobacterial lymphadenitis following initiation of protease‐inhibitor therapy in patients with advanced HIV‐1 disease
  publication-title: Lancet
– volume: 19
  start-page: 232
  year: 1990
  end-page: 4
  article-title: Oral manifestations of AIDS in a heterosexual population in a Zaire hospital
  publication-title: J Oral Pathol Med
– volume: 31
  start-page: 1
  year: 2002
  end-page: 4
  article-title: Oral manifestations in 101 Cambodians with HIV and AIDS
  publication-title: J Oral Pathol Med
– volume: 280
  start-page: 72
  year: 1998
  end-page: 7
  article-title: Recovery of the immune system with antiretroviral therapy: the end of opportunism?
  publication-title: J Am Med Assoc
– volume: 94
  start-page: 454
  year: 2002
  end-page: 9
  article-title: Regression of HIV parotid swellings after antiviral therapy: case reports with computed tomographic scan evidence
  publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol Endod
– volume: 10
  start-page: 145
  year: 2004
  end-page: 50
  article-title: Effect of PI‐HAART on the prevalence of oral lesions in HIV‐I infected patients. A Greek study
  publication-title: Oral Dis
– volume: 12
  start-page: 3
  issue: Suppl. 1
  year: 2006
  article-title: US1 HIV – changing patterns in HAART era, patients’ quality of life and occupational risks
  publication-title: Oral Dis
– volume: 77
  start-page: 344
  year: 1994
  end-page: 9
  article-title: Oral manifestations associated with HIV‐related disease as markers for immune suppression and AIDS
  publication-title: Oral Surg Oral Med Oral Pathol
– volume: 50
  start-page: 506
  year: 2009
  end-page: 12
  article-title: National expansion of antiretroviral treatment in Thailand, 2000–2007: program scale‐up and patient outcomes
  publication-title: J Acquir Immune Defic Syndr
– volume: 185
  start-page: 188
  year: 2002
  end-page: 95
  article-title: Antiretroviral therapy with protease inhibitors has an early, immune reconstitution‐independent beneficial effect on virulence and oral candidiasis in human immunodeficiency virus‐infected subjects
  publication-title: J Infect Dis
– volume: 2
  start-page: 415
  year: 1989
  end-page: 25
  article-title: Parotid gland enlargement and xerostomia associated with labial sialadenitis in HIV‐infected patients
  publication-title: J Autoimmun
– volume: 9
  start-page: 55
  year: 2003
  end-page: 61
  article-title: Parotid gland involvement in advanced AIDS
  publication-title: Oral Dis
– volume: 19
  start-page: 482
  year: 1990
  end-page: 5
  article-title: Oral lesions in Mexican HIV‐infected patients
  publication-title: J Oral Pathol Med
– volume: 134
  start-page: 854
  year: 2001
  end-page: 60
  article-title: Associations of symptoms and health‐related quality of life: findings from a national study of persons with HIV infection
  publication-title: Ann Intern Med
– volume: 102
  start-page: 318
  year: 2006
  end-page: 24
  article-title: Salivary gland function in HIV‐infected patients treated with highly active antiretroviral therapy (HAART)
  publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol Endod
– volume: 157
  start-page: 553
  year: 1991
  end-page: 6
  article-title: Parotid enlargement in children seropositive for human immunodeficiency virus: imaging findings
  publication-title: AJR Am J Roentgenol
– volume: 63
  start-page: 86
  year: 2003
  end-page: 91
  article-title: Perceived oral health status, unmet needs, and barriers to dental care among HIV/AIDS patients in a North Carolina cohort: impacts of race
  publication-title: J Public Health Dent
– volume: 3
  start-page: 1
  issue: Suppl. 1
  year: 1997
  end-page: 5
  article-title: Oral lesions in a group of Thai people with AIDS
  publication-title: Oral Dis
– volume: 37
  start-page: 99
  year: 2008
  end-page: 106
  article-title: Oral lesions as predictors of highly active antiretroviral therapy failure in Brazilian HIV‐infected children
  publication-title: J Oral Pathol Med
– volume: 11
  start-page: 57
  year: 2002
  end-page: 70
  article-title: Associations of self‐reported oral health with physical and mental health in a nationally representative sample of HIV persons receiving medical care
  publication-title: Qual Life Res
– volume: 82
  start-page: 719
  year: 2003
  end-page: 24
  article-title: Alteration in salivary function in early HIV infection
  publication-title: J Dent Res
– volume: 7
  start-page: 205
  year: 2001
  end-page: 10
  article-title: Orofacial effects of antiretroviral therapies
  publication-title: Oral Dis
– volume: 112
  start-page: 187
  year: 1986
  end-page: 92
  article-title: Oral findings in people with or at a high risk for AIDS; a study of 375 homosexual males
  publication-title: J Am Dent Assoc
– volume: 112
  start-page: 3
  year: 1990
  end-page: 10
  article-title: A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA‐DR5
  publication-title: Ann Intern Med
– volume: 22
  start-page: 289
  year: 1993
  end-page: 91
  article-title: EC‐Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Human Immunodeficiency Virus. Classification and diagnostic criteria for oral lesions in HIV infection
  publication-title: J Oral Pathol Med
– volume: 57
  start-page: 749
  year: 1998
  article-title: Parotid lipomatosis in HIV positive patients: a new clinical disorder associated with protease inhibitors
  publication-title: Ann Rheum Dis
– volume: 87
  start-page: 437
  year: 1999
  end-page: 41
  article-title: Frequency of oropharyngeal candidiasis in HIV‐infected patients on protease inhibitor therapy
  publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol Endod
– volume: 189
  start-page: 686
  year: 2004
  end-page: 98
  article-title: Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus
  publication-title: J Infect Dis
– volume: 27
  start-page: 176
  year: 1998
  end-page: 9
  article-title: Oral manifestations of HIV infection in 600 South African patients
  publication-title: J Oral Pathol Med
– volume: 23
  start-page: 85
  year: 1999
  end-page: 96
  article-title: Classification, diagnostic criteria, and treatment recommendations for orofacial manifestations in HIV‐infected pediatric patients. Collaborative Workgroup on Oral Manifestations of Pediatric HIV Infection
  publication-title: J Clin Pediatr Dent
– volume: 92
  start-page: 623
  year: 2001
  end-page: 8
  article-title: The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV‐infected patients: a UK study
  publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol Endod
– volume: 15
  start-page: S11
  issue: Suppl. 2
  year: 2001
  end-page: 5
  article-title: Immune restoration and CD4+ T‐cell function with antiretroviral therapies
  publication-title: AIDS
– volume: 10
  start-page: 173
  year: 2002
  end-page: 7
  article-title: Anti‐fungal therapy at the HAART of viral therapy
  publication-title: Trends Microbiol
– volume: 61
  start-page: 1158
  year: 1982
  end-page: 62
  article-title: A comparison of whole mouth resting and stimulated salivary measurements procedures
  publication-title: J Dent Res
– volume: 1
  start-page: 73
  year: 2003
  end-page: 9
  article-title: Oral mucosal lesions in a UK HIV/AIDS oral medicine clinic. A nine year, cross‐sectional, prospective study
  publication-title: Oral Health Prev Dent
– volume: 79
  start-page: 1502
  year: 2000
  end-page: 7
  article-title: The prevalence of xerostomia and salivary gland hypofunction in a cohort of HIV‐positive and at‐risk women
  publication-title: J Dent Res
– volume: 12
  start-page: 537
  year: 2006
  end-page: 42
  article-title: Oral manifestations in HIV/AIDS infected patients from India
  publication-title: Oral Dis
– year: 2009
  article-title: Hyposalivation, xerostomia and oral health status of HIV‐infected subjects in Thailand before HAART era
  publication-title: J Oral Pathol Med
– volume: 83
  start-page: 145
  year: 2004
  end-page: 50
  article-title: Incidence of oral lesions in HIV‐1 infected women: reduction with HAART
  publication-title: J Dent Res
– volume: 39
  start-page: 717
  year: 2004
  end-page: 24
  article-title: Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women’s Interagency HIV Study
  publication-title: Clin Infect Dis
– volume: 15
  start-page: 52
  year: 2009
  end-page: 60
  article-title: Effect of HAART on salivary gland function in the Women’s Interagency HIV Study (WIHS)
  publication-title: Oral Dis
– volume: 14
  start-page: 143
  year: 2000
  end-page: 7
  article-title: Cystic lymphoepithelial lesions of the parotid gland in HIV‐1 infection
  publication-title: AIDS Patient Care STDs
– volume: 29
  start-page: 336
  year: 2000
  end-page: 41
  article-title: Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy
  publication-title: J Oral Pathol Med
– volume: 5
  start-page: 5
  year: 2008
  end-page: 12
  article-title: Oral manifestations associated with HIV infection
  publication-title: Curr HIV/AIDS Rep
– volume: 83
  start-page: 869
  year: 2004
  end-page: 73
  article-title: Dental caries in HIV‐seropositive women
  publication-title: J Dent Res
– volume: 30
  start-page: 783
  year: 2002
  end-page: 8
  article-title: Saliva: a fountain of opportunity
  publication-title: J Calif Dent Assoc
– volume: 5
  start-page: 294
  year: 1999
  end-page: 8
  article-title: Association of HIV viral load with oral diseases
  publication-title: Oral Dis
– volume: 89
  start-page: 299
  year: 2000
  end-page: 304
  article-title: Changing prevalence of oral manifestations of human immune‐deficiency virus in the era of protease inhibitor therapy
  publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol Endod
– volume: 333
  start-page: 450
  year: 1995
  end-page: 1
  article-title: Time to hit HIV, early and hard
  publication-title: N Engl J Med
– volume: 300
  start-page: 555
  year: 2008
  end-page: 70
  article-title: Antiretroviral treatment of adult HIV infection: 2008 recommendations of the international AIDS society USA panel
  publication-title: JAMA
– volume: 34
  start-page: 413
  year: 1998
  end-page: 20
  article-title: Detection of HPV‐16 genome in human oral cancers and potentially malignant lesions from India
  publication-title: Oral Oncol
– volume: 41
  start-page: 33
  year: 1996
  end-page: 6
  article-title: Oral conditions and their social impact among HIV dental patients
  publication-title: Aust Dent J
– volume: 351
  start-page: 1682
  year: 1998
  end-page: 6
  article-title: Long‐lasting recovery in CD4 T‐cell function and viral‐load reduction after highly active antiretroviral therapy in advanced HIV‐1 disease
  publication-title: Lancet
– volume: 14
  start-page: 549
  year: 2000
  end-page: 54
  article-title: Medication usage and dental caries outcome‐related variables in HIV/AIDS patients
  publication-title: AIDS Patient Care STDs
– volume: 357
  start-page: 1411
  year: 2001
  end-page: 2
  article-title: Effect of highly active antiretroviral therapy on frequency of oral warts
  publication-title: Lancet
– volume: 22
  start-page: 327
  year: 1990
  end-page: 30
  article-title: Nail and mucocutaneous hyperpigmentation with azidothymidine therapy
  publication-title: J Am Acad Dermatol
– volume: 20
  start-page: 632
  year: 1991
  end-page: 6
  article-title: Cutaneo‐mucosal hyperpigmentation in AIDS. 4 cases [in French]
  publication-title: Presse Med
– volume: 21
  start-page: 20
  year: 1999
  end-page: 5
  article-title: Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case‐control study
  publication-title: J Acquir Immune Defic Syndr
– volume: 103
  start-page: 1063
  year: 1989
  end-page: 6
  article-title: Immunocytochemical identification of HIV (p24) antigen in parotid lymphoid lesions
  publication-title: J Laryngol Otol
– volume: 82
  start-page: 39
  year: 2003
  end-page: 50
  article-title: The changing clinical spectrum of human immunodeficiency virus (HIV)‐related oral lesions in 1000 consecutive patients: a 12‐year study in a referral center in Mexico
  publication-title: Medicine (Baltimore)
– volume: 8
  start-page: 90
  year: 2002
  end-page: 4
  article-title: Changes in the prevalence of HIV‐associated mucosal disease at a dedicated clinic over 7 years
  publication-title: Oral Dis
– volume: 14
  start-page: 627
  year: 2000
  end-page: 35
  article-title: Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS?
  publication-title: AIDS Patient Care STDS
– volume: 43
  start-page: 247
  year: 1999
  end-page: 51
  article-title: HIV‐1 (p24)‐positive multinucleated giant cells in HIV‐associated lymphoepithelial lesion of the parotid gland. A report of two cases
  publication-title: Acta Cytol
– ident: e_1_2_6_38_2
  doi: 10.1086/338637
– ident: e_1_2_6_23_2
  doi: 10.1023/A:1014443418737
– ident: e_1_2_6_16_2
  doi: 10.1067/moe.2001.118902
– ident: e_1_2_6_25_2
  doi: 10.1111/j.1600-0714.1993.tb01074.x
– ident: e_1_2_6_31_2
  doi: 10.1016/S0966-842X(02)02330-2
– ident: e_1_2_6_57_2
  doi: 10.1111/j.1601-0825.2006.01306_12.x
– ident: e_1_2_6_42_2
  doi: 10.1086/381504
– ident: e_1_2_6_12_2
  doi: 10.1016/S1079-2104(00)70092-8
– ident: e_1_2_6_55_2
  doi: 10.2214/ajr.157.3.1651645
– ident: e_1_2_6_68_2
  doi: 10.1089/108729100317920
– ident: e_1_2_6_7_2
  doi: 10.1111/j.1600-0714.1990.tb00791.x
– ident: e_1_2_6_29_2
  doi: 10.1097/00126334-199905010-00003
– ident: e_1_2_6_46_2
  doi: 10.1111/j.1600-0714.1998.tb01936.x
– ident: e_1_2_6_52_2
  doi: 10.1089/108729100750018317
– ident: e_1_2_6_40_2
  doi: 10.1034/j.1600-0714.2000.290708.x
– ident: e_1_2_6_66_2
  doi: 10.1017/S0022215100110990
– ident: e_1_2_6_44_2
  doi: 10.1016/S1368-8375(98)00028-1
– ident: e_1_2_6_51_2
  doi: 10.1177/154405910408301109
– volume: 3
  start-page: 1
  issue: 1
  year: 1997
  ident: e_1_2_6_11_2
  article-title: Oral lesions in a group of Thai people with AIDS
  publication-title: Oral Dis
– volume: 77
  start-page: 84
  year: 1998
  ident: e_1_2_6_50_2
  article-title: Severe caries and the use of protease inhibitors (abstract)
  publication-title: J Dent Res
– ident: e_1_2_6_37_2
  doi: 10.1034/j.1601-0825.2002.1o787.x
– ident: e_1_2_6_6_2
  doi: 10.14219/jada.archive.1986.0321
– volume: 20
  start-page: 632
  year: 1991
  ident: e_1_2_6_34_2
  article-title: Cutaneo‐mucosal hyperpigmentation in AIDS. 4 cases [in French]
  publication-title: Presse Med
– ident: e_1_2_6_43_2
  doi: 10.1016/S0140-6736(97)04352-3
– ident: e_1_2_6_8_2
  doi: 10.1111/j.1600-0714.1990.tb00832.x
– ident: e_1_2_6_30_2
  doi: 10.1086/338445
– ident: e_1_2_6_41_2
  doi: 10.1177/154405910408300212
– ident: e_1_2_6_9_2
  doi: 10.1111/j.1600-0714.1992.tb00994.x
– volume: 30
  start-page: 783
  year: 2002
  ident: e_1_2_6_61_2
  article-title: Saliva: a fountain of opportunity
  publication-title: J Calif Dent Assoc
  doi: 10.1080/19424396.2002.12223320
– ident: e_1_2_6_2_2
  doi: 10.1016/S0140-6736(97)10291-4
– ident: e_1_2_6_49_2
  doi: 10.1111/j.1601-0825.1999.tb00092.x
– ident: e_1_2_6_59_2
  doi: 10.1034/j.1601-0825.2003.02868.x
– ident: e_1_2_6_36_2
  doi: 10.1016/S0140-6736(00)04578-5
– ident: e_1_2_6_10_2
  doi: 10.1016/0030-4220(94)90195-3
– ident: e_1_2_6_24_2
  doi: 10.1097/QAI.0b013e3181967602
– ident: e_1_2_6_32_2
  doi: 10.1111/j.1601-0825.2006.01232.x
– ident: e_1_2_6_65_2
  doi: 10.1086/423181
– ident: e_1_2_6_48_2
  doi: 10.1046/j.1601-0825.2003.00994.x
– year: 2009
  ident: e_1_2_6_20_2
  article-title: Hyposalivation, xerostomia and oral health status of HIV‐infected subjects in Thailand before HAART era
  publication-title: J Oral Pathol Med
– ident: e_1_2_6_17_2
  doi: 10.1097/00005792-200301000-00004
– ident: e_1_2_6_3_2
  doi: 10.1097/00002030-200102002-00003
– ident: e_1_2_6_4_2
  doi: 10.1001/jama.300.5.555
– ident: e_1_2_6_33_2
  doi: 10.1016/0190-9622(90)70039-K
– ident: e_1_2_6_60_2
  doi: 10.7326/0003-4819-112-1-3
– ident: e_1_2_6_14_2
  doi: 10.1111/j.1600-0714.2007.00598.x
– ident: e_1_2_6_26_2
  doi: 10.1177/00220345820610100901
– ident: e_1_2_6_64_2
  doi: 10.1016/j.tripleo.2005.07.021
– ident: e_1_2_6_56_2
  doi: 10.1067/moe.2002.126025
– ident: e_1_2_6_18_2
  doi: 10.1177/00220345000790071201
– ident: e_1_2_6_19_2
  doi: 10.1177/154405910308200912
– ident: e_1_2_6_54_2
  doi: 10.1016/0896-8411(89)90170-4
– ident: e_1_2_6_13_2
  doi: 10.1007/s11904-008-0002-8
– ident: e_1_2_6_47_2
  doi: 10.1111/j.1834-7819.1996.tb05652.x
– ident: e_1_2_6_28_2
  doi: 10.1016/S1079-2104(99)70242-8
– ident: e_1_2_6_22_2
  doi: 10.7326/0003-4819-134-9_Part_2-200105011-00009
– ident: e_1_2_6_35_2
  doi: 10.1034/j.1600-0714.2002.310101.x
– ident: e_1_2_6_45_2
  doi: 10.1111/j.1752-7325.2003.tb03480.x
– ident: e_1_2_6_63_2
  doi: 10.1034/j.1601-0825.2001.70401.x
– volume: 23
  start-page: 85
  year: 1999
  ident: e_1_2_6_21_2
  article-title: Classification, diagnostic criteria, and treatment recommendations for orofacial manifestations in HIV‐infected pediatric patients. Collaborative Workgroup on Oral Manifestations of Pediatric HIV Infection
  publication-title: J Clin Pediatr Dent
– ident: e_1_2_6_58_2
  doi: 10.1111/j.1601-0825.2008.01456.x
– ident: e_1_2_6_62_2
  doi: 10.1136/ard.57.12.749
– ident: e_1_2_6_5_2
  doi: 10.1056/NEJM199508173330710
– ident: e_1_2_6_15_2
  doi: 10.1089/10872910050206540
– ident: e_1_2_6_53_2
  doi: 10.1067/moe.2003.230
– ident: e_1_2_6_67_2
  doi: 10.1159/000330987
– ident: e_1_2_6_27_2
  doi: 10.1001/jama.280.1.72
– volume: 1
  start-page: 73
  year: 2003
  ident: e_1_2_6_39_2
  article-title: Oral mucosal lesions in a UK HIV/AIDS oral medicine clinic. A nine year, cross‐sectional, prospective study
  publication-title: Oral Health Prev Dent
SSID ssj0017341
Score 2.2556722
Snippet J Oral Pathol Med (2010) 39: 397–406 Background:  The aim of this study was to determine the effects of long‐term use of highly active antiretroviral therapy...
J Oral Pathol Med (2010) 39 : 397–406 Background:  The aim of this study was to determine the effects of long‐term use of highly active antiretroviral therapy...
The aim of this study was to determine the effects of long-term use of highly active antiretroviral therapy (HAART) on oral health status of HIV-infected...
J Oral Pathol Med (2010) 39: 397-406Background: The aim of this study was to determine the effects of long-term use of highly active antiretroviral therapy...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
istex
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 397
SubjectTerms Adult
Age
Antiretroviral Therapy, Highly Active - adverse effects
Burning
Case-Control Studies
CD4 antigen
Cross-Sectional Studies
Data processing
Dental caries
Dental Caries - complications
Female
HAART
Health Status
highly active antiretroviral therapy
HIV
HIV Infections - complications
HIV Infections - drug therapy
Human immunodeficiency virus
Humans
Infection
Linear Models
Logistic Models
Male
Middle Aged
Mouth Diseases - complications
Oral Health
oral lesion
Pain
Periodontal Index
Pigmentation Disorders - etiology
Regression analysis
risk factor
Saliva
salivary flow rate
Salivation - drug effects
Secretory Rate
Side effects
Thailand
Time Factors
Young Adult
Title Effects of long-term use of HAART on oral health status of HIV-infected subjects
URI https://api.istex.fr/ark:/67375/WNG-B0T8RM4K-S/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1600-0714.2009.00875.x
https://www.ncbi.nlm.nih.gov/pubmed/20202089
https://www.proquest.com/docview/733282498
https://www.proquest.com/docview/744697278
https://pubmed.ncbi.nlm.nih.gov/PMC3217232
Volume 39
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwELYQPdBLH_S19CEfqt6ycjZ2nBwpLd2CoBVdWm5W7ExotShBZCOhnvoT-I39JZ1xNhEBVKGqt9Xak5Wdmfib7DffMPYaXIR3Gp03tgoTlBwgwDxEBzpXNlM4CL48em8_nh7KnSN1tOQ_US1Mqw_Rv3CjyPDPawrwzNbDII-pKlqHspOdROw9JjxJ1C3CRwe9klSoI9_EUqRCBnSkD0k9N15ocFLdoU0_vwmGXmdTXka5_pjavs_m3QJbdsp83Czs2P28ov34f3bgAbu3RLN8s3W_h2wFynW29o4YSNRE7hGbterINa8KflKVx79_XdBZwJsa6KvpJuJpXpWcdAJ4W5PJqcap8RbTj1_RoOWLQc7rxtJbo_oxO9x-P9uaBstGDoFTmI4EMi0KKV0c5rku4rxQiOLCInMkfmOltYQbUmlj0IVyYSZDEJmNBGTWJYUTLnrCVsuqhGeMS-u0AwXUfE_GNkmAEmBS2ZcQTxIxYrq7acYtVc6p2caJuZTt4GxDu0Y9OFPjd82cj1jYW562Sh-3sHnj_aI3yM7mxJTDsW_7H8xbMUsO9uSu-TJivHMcg_FLf8pkJVRNbXQUYdYr0-QvUzBlTxFn4pSnrav1vzehxYskxWUPnLCfQOrhw5Hyx3evIh5Ra7JoMmLK-9it12x2Pn3GDxv_aPec3e0IGCJ8wVYXZw28RFy3sK98xP4BEuQ-ow
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwELYqONBLX_SxbQEfUG9ZORs7To60QMNjl4ouLTcrdpy2YpVUZCOhnvoT-I38EmacTURaVKGK22rt2ZWdmfU33pnvI2TTmgCeNDhvqAUkKJm1HuQh0pOZ0KmAQevao8eTMDnh-6fidCEHhL0wDT9Ed-GGkeF-rzHA8UK6H-UhtkVLn7e8kwC-hwAol1Hg2-VXxx2XlC8DJ2PJYsY9PNT7ZT23flLvrFrGbb-4DYj-XU95E-e6g2r3MZm1S2zqU86G9VwPza8_2B_vaQ-ekEcLQEu3Gg98Sh7Y4hlZ2cYiJNSRWyXThiC5omVOZ2Xx7er3JR4HtK4svpVsAaSmZUGRKoA2bZkU25xqZ5HsfQGDpmTMZrSqNV4cVc_Jye7O9EPiLbQcPCMgI_F4nOecm9DPMpmHWS4AyPl5apD_RnOtETrEXIdW5sL4KfctS3XAbKpNlBtmghdkqSgL-4pQro00VljU3-OhjiKLOTAS7XMbjiI2ILJ9asosiM5Rb2OmbiQ8MFvhrqEMZ6zcrqmLAfE7y58N2ccdbN45x-gM0vMzLJaDsa-Tj-o9m0bHY36gPg8IbT1HQQjj_zJpYcu6UjIIIPHlcfSPKZC1xwA1YcrLxte67xvh4lkUw7J7XthNQALx_kjx47sjEg9QnSwYDYhwTnbnNav9o0_w4vV_2m2QlWQ6PlSHe5ODN-RhW4_B_LdkaX5e2zWAeXO97sL3Gu37Qr4
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF6hVgIuvKHhuQfEzZEd78M-toSQtjRUJYXeVt71LkWp7KqOpaonfgK_kV_CzDq2aqhQhbhF2R1Hu_7G-40z8w0hr62J4U4DeIXmEKDk1gYQh8hA5lxnHAatL4_em4npIds54ker_CeshWn0IboXbugZ_nmNDn6au76TC6yKlhFrZSeBew-BT64zESaI8PFBJyUVydh3sQzTkAV4pvezeq68Uu-oWsddP7-Kh_6ZTnmZ5vpzanKXLNoVNukpi2G91ENz8Zv44__ZgnvkzorO0s0Gf_fJDVs8ILfGmIKEXeQeknkjj1zR0tGTsvj68_sPPAxoXVn8aroJhJqWBUWhANoUZVIscqq9xXT7Mxg0CWM2p1Wt8bVR9YgcTt7N306DVSeHwHCIRwKWOseYEVGeSydyx4HGRS4zqH6jmdZIHFKmhZWOmyhjkQ0zHYc20yZxJjTxY7JWlIXdIJRpI43lFrvvMaGTxGIEjDL7zIpREg6IbG-aMiuZc-y2caIuhTswW-GuYRPOVPldU-cDEnWWp43UxzVs3nhcdAbZ2QJT5WDsy-y92grnycEe21WfBoS2wFHgwPivTFbYsq6UjGMIe1ma_GUKxOwpEE2Y8qSBWvd7I1w8oB2W3QNhNwHlw_sjxbdjLyMeY2-yeDQg3GPs2mtWOx_34cPTf7R7RW7ujyfqw_Zs9xm53SZjhNFzsrY8q-0L4HhL_dI77y8CvUF2
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+long-term+use+of+HAART+on+oral+health+status+of+HIV-infected+subjects&rft.jtitle=Journal+of+oral+pathology+%26+medicine&rft.au=Nittayananta%2C+Wipawee&rft.au=Talungchit%2C+Sineepat&rft.au=Jaruratanasirikul%2C+Sutep&rft.au=Silpapojakul%2C+Kachornsakdi&rft.date=2010-05-01&rft.issn=0904-2512&rft.eissn=1600-0714&rft.volume=39&rft.issue=5&rft.spage=397&rft.epage=406&rft_id=info:doi/10.1111%2Fj.1600-0714.2009.00875.x&rft_id=info%3Apmid%2F20202089&rft.externalDocID=PMC3217232
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0904-2512&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0904-2512&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0904-2512&client=summon